Close menu




January 17th, 2022 | 15:57 CET

Which stocks should investors buy? BioNTech, Desert Gold, Unilever in focus

  • Investments
Photo credits: pixabay.com

The start of the week in Germany has been mixed. At 15,937 points, the German benchmark index DAX is almost unchanged from the close of trading last Friday. No impulses are expected from the U.S. today, as the stock market there remains closed for the holiday. The MDAX last traded at 34,667 points (+0.24%), TecDAX at 3,563 points (+0.53%) and SDAX at 15,872 points with 0.07% in the red. Detached from the indices, investors have special opportunities today in individual stocks.

time to read: 1 minutes | Author: Mario Hose
ISIN: BIONTECH SE SPON. ADRS 1 | US09075V1026 , DESERT GOLD VENTURES | CA25039N4084 , UNILEVER PLC LS-_031111 | GB00B10RZP78

Table of contents:


    Bet on a reverse movement?

    Unilever is one of the heavyweights on the stock exchange and, with 4,900 executed orders, is at the top of the most traded shares on Tradegate. The share is currently trading at EUR 44.055, down 6.56%. Those who bet on falling prices at the beginning of that trade were able to achieve a good performance, as the share starts the day at EUR 47.20. The share of BioNTech is also lighter today and was last quoted EUR 169.30 about 1.5% in the red. With over 4,000 executions, the stock ranks second most active company on Tradegate today.

    More than one million ounces of gold creates stability

    Canadian gold company Desert Gold Ventures surprised the market today with a positive announcement. The company has identified deposits of approximately 1.07 million ounces of gold on its lands in previous exploration and drilling programs - split into Measured and Indicated Mineral Resources of 310,300 ounces and Inferred Mineral Resources of 769,200 ounces of Gold.

    Desert Gold’s President & CEO Jared Scharf commented, “The publication of this initial Mineral Resource is a significant milestone for the Company and represents a great starting point. We believe, that with more drilling, the Company will be able to significantly expand on these resources and develop new resource areas like the Gourbassi North West discovery. We expect a busy 2022 as we work towards a 20,000 metre plus drill program with high expectations of the results.”

    Desert Gold's shares are up 3.96% to EUR 0.1025. The market capitalization is currently EUR 15 million, hard to imagine that the valuation will remain so low permanently.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Armin Schulz on May 21st, 2026 | 07:20 CEST

    Is the Gold Price Falling? Buy the Dip! Why Barrick Mining, Desert Gold Ventures, and Agnico Eagle Mines Now Offer Attractive Entry Points

    • Mining
    • Gold
    • Commodities
    • Investments
    • Africa
    • Production

    Following the recent decline in the gold price, alarm bells are ringing for many investors. But those who look closely will recognize a familiar market dynamic. Every overheated rally is typically followed by a healthy consolidation phase. It is precisely this correction that may create a rare window of opportunity for strategically positioned investors, as the precious metal's fundamental upward momentum remains intact thanks to expectations of interest rate cuts and central bank purchases. Those willing to take a contrarian view at this stage could benefit disproportionately from the next recovery phase. Three industry players with different strategic profiles illustrate how current uncertainty can be transformed into potential returns: Barrick Mining, Desert Gold, and Agnico Eagle.

    Read

    Commented by Fabian Lorenz on May 20th, 2026 | 08:10 CEST

    Is This Gold Gem the Investment Opportunity of the Year? Lahontan Gold Set to Become a Producer!

    • Mining
    • Gold
    • Silver
    • Nevada
    • geopolitics
    • Investments

    As the gold price continues to consolidate, this gold gem may present the investment opportunity of the year. Lahontan Gold is aiming to make history in the coming months by advancing toward gold production in Nevada. In its latest investor presentation, management confirmed that preparations for mine construction remain fully on track. In addition, a new resource estimate is expected to be released in the coming weeks. If projections from major banks such as Goldman Sachs are correct, the gold price could soon regain upward momentum, with some forecasts suggesting levels above USD 5,000 by the end of 2026. This is being driven in part by stronger-than-expected central bank gold purchases. With potential production costs of around USD 1,200 per ounce, Lahontan Gold could benefit significantly. At current levels, the stock still appears attractively valued.

    Read

    Commented by André Will-Laudien on May 20th, 2026 | 08:05 CEST

    Takeover Candidates for 2026! The Life Sciences Sector Is Heating Up: Evotec, BioNxt Solutions, BioNTech, and Formycon in Focus!

    • Biotechnology
    • LifeSciences
    • Biotech
    • Investments

    In recent months, the stock market has focused primarily on high-tech and defence stocks. While this strategy may have worked well for investors in the short term, it has also pushed several life sciences stocks to levels that some consider overly depressed. The Hamburg-based drug discovery company Evotec has lost around 75% of its market value over the past three years, with similar declines seen at BioNTech, Formycon, and BioNxt Solutions. Yet some pipelines are indeed valuable and backed by years of research. For a buyer with deep pockets, this could represent an attractive opportunity, as much of the costly early-stage work has already been completed. We are looking at a sector that has been unjustly forgotten. Where do opportunities lie for risk-conscious investors?

    Read